Global burden and forecast of infectious diseases attributable to drug use: evidence from GBD 2021.

ABSTRACT:

Background

Drug use is a significant risk factor for infectious diseases, yet a comprehensive global assessment of this burden-encompassing trends, inequalities, and forecasts-is lacking, hindering progress toward World Health Organization (WHO)'s 2030 elimination targets. This study provides the first such analysis, leveraging the Global Burden of Disease (GBD) 2021 study to quantify the specific burden of infectious diseases attributable to drug use.

Methods

Using data from 204 countries and territories in the GBD 2021 study, we analyzed deaths and disability-adjusted life years (DALYs) from HIV/AIDS, sexually transmitted infections (STIs), and other infectious diseases (primarily acute hepatitis B and C) attributable to drug use, following the GBD risk attribution framewo

SUBMITTER: Gong X 

PROVIDER: S-EPMC12745377 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature